Severity of COVID-19 in children with cancer: Report from the United Kingdom Paediatric Coronavirus Cancer Monitoring Project
AuthorsMillen, G. C.
Cazier, J. B.
Feltbower, R. G.
Glaser, A. W.
Grundy, R. G.
Lee, L. Y. W.
Phillips, R. S.
Stiller, C. A.
Kearns, P. R.
AffiliationCancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.
MetadataShow full item record
AbstractBackground: Children with cancer are frequently immunocompromised. While children are generally thought to be at less risk of severe SARS-CoV-2 infection than adults, comprehensive population-based evidence for the risk in children with cancer is unavailable. We aimed to produce evidence of the incidence and outcomes from SARS-CoV-2 in children with cancer attending all hospitals treating this population across the UK. Methods: Retrospective and prospective observational study of all children in the UK under 16 diagnosed with cancer through data collection from all hospitals providing cancer care to this population. Eligible patients tested positive for SARS-CoV-2 on reverse transcription polymerase chain reaction (RT-PCR). The primary end-point was death, discharge or end of active care for COVID-19 for those remaining in hospital. Results: Between 12 March 2020 and 31 July 2020, 54 cases were identified: 15 (28%) were asymptomatic, 34 (63%) had mild infections and 5 (10%) moderate, severe or critical infections. No patients died and only three patients required intensive care support due to COVID-19. Estimated incidence of hospital identified SARS-CoV-2 infection in children with cancer under 16 was 3%. Conclusions: Children with cancer with SARS-CoV-2 infection do not appear at increased risk of severe infection compared to the general paediatric population. This is reassuring and supports the continued delivery of standard treatment.
CitationMillen GC, Arnold R, Cazier JB, Curley H, Feltbower RG, Gamble A, et al. Severity of COVID-19 in children with cancer: Report from the United Kingdom Paediatric Coronavirus Cancer Monitoring Project. Br J Cancer. 2020.
JournalBritish Journal of Cancer
- Human and novel coronavirus infections in children: a review.
- Authors: Rajapakse N, Dixit D
- Issue date: 2021 Feb
- Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England.
- Authors: Forbes H, Morton CE, Bacon S, McDonald HI, Minassian C, Brown JP, Rentsch CT, Mathur R, Schultze A, DeVito NJ, MacKenna B, Hulme WJ, Croker R, Walker AJ, Williamson EJ, Bates C, Mehrkar A, Curtis HJ, Evans D, Wing K, Inglesby P, Drysdale H, Wong AYS, Cockburn J, McManus R, Parry J, Hester F, Harper S, Douglas IJ, Smeeth L, Evans SJW, Bhaskaran K, Eggo RM, Goldacre B, Tomlinson LA
- Issue date: 2021 Mar 18
- Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.
- Authors: Poletti P, Tirani M, Cereda D, Trentini F, Guzzetta G, Sabatino G, Marziano V, Castrofino A, Grosso F, Del Castillo G, Piccarreta R, Andreassi A, Melegaro A, Gramegna M, Ajelli M, Merler S, ATS Lombardy COVID-19 Task Force.
- Issue date: 2021 Mar 1
- Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean.
- Authors: Mattar S, Martinez-Bravo C, Rivero R, Contreras H, Faccini-Martínez ÁA, Guzman-Teran C, Galeano K, Alvis-Guzman N, Contreras V, Arrieta G, Gonzalez-Tous M, Miranda J, Ospina M, Camargo-Assis F, Mercado-Reyes M, Garay E, Garcia-Perez A, Lopez Y, Tique V
- Issue date: 2020 Dec 7
- COVID-19 symptom surveillance in immunocompromised children and young people in the UK: a prospective observational cohort study.
- Authors: Shaunak M, Patel R, Driessens C, Mills L, Leahy A, Gbesemete D, Owens DR, Lucas JS, Faust SN, de Graaf H, ImmunoCOVID19 study group.
- Issue date: 2021 Mar 17